PST3 CLOPIDOGREL VERSUS ASPIRIN IN HIGH-RISK PATIENTS WITH RECENT ISCHEMIC STROKE ORTRANSIENT ISCHEMIC ATTACK- COST-EFFECTIVENESS ANALYSIS IN ITALY
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67612-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67612-7/fulltext
Title :
PST3 CLOPIDOGREL VERSUS ASPIRIN IN HIGH-RISK PATIENTS WITH RECENT ISCHEMIC STROKE ORTRANSIENT ISCHEMIC ATTACK- COST-EFFECTIVENESS ANALYSIS IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67612-7&doi=10.1016/S1098-3015(10)67612-7
First page :
Section Title :
Open access? :
No
Section Order :
193